Michael Clark, PMP

Smart Imaging Strategy to Accelerate Drug Development
MichaelClark

Michael Clark, PMP

Chief Operating Officer
Bone Health Expert
Michael Clark is the Chief Operating Officer (COO) at Image Analysis Group (IAG), a leading provider of image analysis solutions for the biotechnology and pharmaceutical industries. He has been in this role since January 2019, based in London, United Kingdom. Mr. Clark brings extensive experience in clinical project management and operations to his role at IAG. He has a background in managing global clinical programs and implementing project management offices (PMOs) in previous positions. Michael Clark's expertise in clinical trials and medical imaging is relevant to bone health research. He has been involved in discussions around the use of imaging techniques like DXA (Dual-Energy X-ray Absorptiometry) analysis, which is a key tool for measuring bone mineral density and body composition. At IAG, Clark works alongside other experts who specialize in musculoskeletal imaging and the development of novel therapeutics for rheumatic and autoimmune conditions. This collaboration likely enhances IAG's capabilities in bone health-related imaging and research. Clark's role at IAG involves building teams and scaling capabilities to deliver global-scale imaging clinical trials, which may include studies related to bone health and osteoporosis. His expertise in clinical operations and imaging technology positions him as a key figure in advancing medical imaging applications, including those relevant to bone health research and drug development.